Latest News

December 23, 2015
Seattle Genetics and Bristol-Myers Squibb Announce Initiation of Phase 1/2 Clinical Trial of ADCETRIS® (Brentuximab Vedotin) in Combination with Opdivo® (Nivolumab) in Relapsed or Refractory Non-Hodgkin Lymphoma
December 18, 2015
Bristol-Myers Squibb to Sell its HIV R&D Portfolio to ViiV Healthcare
December 17, 2015
BMS and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Enter Into a Collaboration Agreement as Part of U.S. Immuno-Oncology Rare Population Malignancy Program

Latest Events

Event year list 2019 2018 2017 2016 2015 2014 2013 2012
November 10, 2015 09:30 AM MST
Bristol-Myers Squibb at the Credit Suisse 24th Annual Healthcare Conference

Bristol-Myers Squibb at the Credit Suisse 24th Annual Healthcare Conference

  • View Presentation (opens in new window) (PDF)
October 27, 2015 11:30 AM EST
2015 Third Quarter Results
Press Release
  • Press Release (opens in new window) (PDF233 KB)
  • Quarterly Package of Financial Information (opens in new window) (Excel804 KB)
October 1, 2015 10:05 AM EST
Bristol-Myers Squibb to Present at the Leerink Immuno-Oncology Roundtable